The metabolic disorders drugs market covers medications that are
used in the treatment of metabolic diseases such as diabetes, thyroid,
hyperparathyroidism, hypopituitarism, and hypoadrenalism. Some of the major
drugs used in the treatment of metabolic diseases are Insulin, Methimazole, and
Calcimimetics.
The substantial growth of the market from $90 billion in 2017 to
$124 billion by 2021 is due to the rapid growth of diabetic patients which,
according to the World Health Organization, is expected to be the world’s
seventh leading cause of death in 2030.
In the report, the global metabolic disorder drugs market is
divided into three segments. Anti-diabetic drug occupy the major share,
accounting for more than 95% of the market and the remaining share is occupied
by the other segments, namely, anti-thyroid drugs and others (hyperparathyroidism,
hypopituitarism, hypoadrenalism).
The USA was the largest country in the
metabolic disorder drugs market in 2017, accounting for nearly 35% of the
market share. This was mainly due to large diabetic population and strong
demand for anti-diabetics drugs in the country. China and Germany followed the USA as the next
largest countries in the market.
The metabolic disorder drugs market is fragmented with a number of
large and small organizations. The top five competitors in the market made up more
than 35% of the total market in 2017. Sanofi S.A. was the largest competitor of
the market, followed by Novo Nordisk A/S, AstraZeneca Plc., Johnson &
Johnson and Merck & Co. Sanofi is a global life sciences company focused on
vaccines, rare diseases, multiple sclerosis, immunology, oncology, infectious
diseases, diabetes and cardiovascular solutions and consumer healthcare. The
company was founded in 1994 and is headquartered in Paris, France.
About The
Business Research Company.
The Business Research Company is a Business Intelligence Company
which excels in company, market and consumer research. It
has offices in the UK, the US and India and a network of trained researchers in
15 countries globally.
Contact
Information.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
No comments:
Post a Comment